Results 281 to 290 of about 543,044 (334)

Nanopore sequencing and hybrid assembly: unraveling the genomic landscape of dollar spot with enhanced annotation and drug resistance profiling. [PDF]

Front Fungal Biol
Shi X, Zhao S, Gibbons JG, Jung G.
europepmc   +1 more source

The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. [PDF]

Genes (Basel)
Singam H, Mossad S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Emerging Virulence, Drug Resistance and Future Anti-fungal Drugs for Candida Pathogens.

Current Topics in Medicinal Chemistry, 2018
Increased incidences of Candida infection have augmented morbidity and mortality in human population, particularly among severely immunocompromised patients and those having a long stay in hospitals (nosocomial infections).
V. Srivastava, Rajeev K. Singla, A. Dubey   +2 more
semanticscholar   +4 more sources

Hyaluronic Acid-Based CuS Nanoenzyme Biodegradable Microneedles for Treating Deep Cutaneous Fungal Infection without Drug Resistance.

Nano letters (Print), 2023
Deep cutaneous fungal infection (DCFI) is difficult to be treated by the traditional topical application due to low drug transdermal efficiency, poor fungicidal effect, and easy to develop drug resistance.
Bingjie Wang, Wenshang Zhang, Qi Pan, Jiaojiao Tao, Shuang Li, Tianze Jiang, Xia Zhao   +6 more
semanticscholar   +1 more source

Learning the ABC of oral fungal drug resistance.

Molecular Oral Microbiology, 2015
SummaryATP‐binding cassette (ABC) proteins are ubiquitous in prokaryotes and eukaryotes. They are involved in energy‐dependent transport of molecules across membranes. ABC proteins are often promiscuous transporters that can translocate a variety of substrates.
R. Cannon, A. R. Holmes
semanticscholar   +3 more sources

Elucidating drug resistance in human fungal pathogens.

Future Microbiology, 2014
Fungal pathogens cause life-threatening infections in immunocompetent and immunocompromised individuals. Millions of people die each year due to fungal infections, comparable to the mortality attributable to tuberculosis or malaria. The three most prevalent fungal pathogens are Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
Jinglin L. Xie, Elizabeth J. Polvi, Tanvi Shekhar-Guturja, L. Cowen   +3 more
semanticscholar   +4 more sources

Fungal Drug Resistance Assays [PDF]

, 2009
The increase in opportunistic mycosis as well as the emergence of antifungal resistance and the development of novel antifungal drugs necessitated the development of standard phenotypic drug resistance assays for fungi. Microdilution methods for testing yeasts (CLSI M27-A3 and EUCAST E.Def 7.2 assay) and filamentous fungi (CLSI M38-A2 and EUCAST E.Def ...
Sevtap Arikan, John H. Rex
openaire   +1 more source

Emerging Role of Sphingolipids in Amphotericin B Drug Resistance.

Microbial Drug Resistance, 2023
Invasive fungal infections in humans are common in people with compromised immune systems and are difficult to treat, resulting in high mortality. Amphotericin B (AmB) is one of the main antifungal drugs available to treat these infections.
Kashish Madaan, V. K. Bari
semanticscholar   +1 more source